Q4 2020 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Good day, and welcome to Sartorius and Sartorius Stedim Biotech Conference Call on the Preliminary Full Year 2020 Results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Thank you very much, and welcome, everybody, to our -- today's call and our preliminary results for 2020. As always, at this time of the year, together with Rainer, our CFO, we would like to inform you about the preliminary results of last year. And in addition to that, also give you a guidance for the year 2021. This time, as we already announced half a year ago, when we talked about our half year's figures for last year, we'll also give you an update on our midterm ambition for the year 2025. We will do that first for the Sartorius Group, and then thereafter directly present on the Sartorius Stedim Biotech set of numbers in all those 3 dimensions. And then after that, we are happy to take your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
